Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Glenmark Pharma

Glenmark Pharma

BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 21, 12:46
354.30
-4.85 (-1.35%)
VOLUME 63,558
LIVE
NSE
Nov 21, 12:46
354.05
-5.3 (-1.47%)
VOLUME 2,544,718

Quarterly Results of Glenmark Pharma

------------------- in Rs. Cr. -------------------
Sep '19 Jun '19 Mar '19 Dec '18 Sep '18
Net Sales/Income from operations 1,742.62 1,455.23 1,530.76 1,599.90 1,639.81
Other Operating Income 47.20 43.56 56.52 32.14 39.90
Total Income From Operations 1,789.82 1,498.79 1,587.28 1,632.04 1,679.72
EXPENDITURE
Consumption of Raw Materials 567.59 519.37 254.89 536.55 385.92
Purchase of Traded Goods 92.87 96.61 47.69 90.82 88.11
Increase/Decrease in Stocks 19.69 -9.28 316.88 -2.48 113.40
Power & Fuel -- -- -- -- --
Employees Cost 345.79 220.02 224.23 232.09 312.40
Depreciation 33.32 32.17 26.35 25.70 26.92
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 383.35 363.43 474.85 425.70 388.07
P/L Before Other Inc. , Int., Excpt. Items & Tax 347.21 276.48 242.40 323.65 364.89
Other Income 192.47 68.54 168.39 -84.64 226.30
P/L Before Int., Excpt. Items & Tax 539.67 345.02 410.79 239.01 591.19
Interest 65.17 68.08 52.61 55.18 60.85
P/L Before Exceptional Items & Tax 474.51 276.94 358.18 183.83 530.34
Exceptional Items -- -- -- -- 345.19
P/L Before Tax 474.51 276.94 358.18 183.83 875.52
Tax 42.52 49.10 76.89 14.41 172.95
P/L After Tax from Ordinary Activities 431.99 227.84 281.29 169.42 702.58
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- 26.45 44.98
Net Profit/(Loss) For the Period 431.99 227.84 281.29 195.87 747.56
Equity Share Capital 28.22 28.22 28.22 28.22 28.22
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 15.31 8.07 9.97 6.94 26.49
Diluted EPS 15.31 8.07 9.97 6.94 26.49
EPS After Extra Ordinary
Basic EPS 15.31 8.07 9.97 6.94 26.49
Diluted EPS 15.31 8.07 9.97 6.94 26.49
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for glenmarkpharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.